Evidence map›Paper›PMID 37823470›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Multivariate word properties in fluency tasks reveal markers of Alzheimer's dementia.

Franco J Ferrante, Joaquín Migeot, Agustina Birba, Lucía Amoruso, Gonzalo Pérez, Eugenia Hesse, Enzo Tagliazucchi, Claudio Estienne, Cecilia Serrano, Andrea Slachevsky and 6 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. The include network: Advancing cross-linguistic equity in brain health research.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  7. Article
  8. Benchmarking speech biomarkers of Alzheimer's against cognitive and neural measures.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  9. The landscape of dementia research, diagnosis, treatment, and care in Latin America.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  10. Review
  11. The two faces of elderspeak.NPJ dementia · 2026
    Review
  12. Article
  13. Article
  14. Cognitive Phenotyping of Parkinson's Disease Patients Via Digital Analysis of Spoken Word Properties.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Multivariate word properties in fluency tasks reveal markers of Alzheimer's dementia.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Franco J FerranteCentro de Neurociencias Cognitivas, Universidad de San Andrés, Victoria, Provincia de Buenos Aires, Argentina.
Joaquín MigeotLatin American Brain Health (BrainLat) Institute, Universidad Adolfo Ibáñez, Peñalolén, Región Metropolitana, Chile.
Agustina BirbaCentro de Neurociencias Cognitivas, Universidad de San Andrés, Victoria, Provincia de Buenos Aires, Argentina.
Lucía AmorusoCentro de Neurociencias Cognitivas, Universidad de San Andrés, Victoria, Provincia de Buenos Aires, Argentina.
Gonzalo PérezCentro de Neurociencias Cognitivas, Universidad de San Andrés, Victoria, Provincia de Buenos Aires, Argentina.
Eugenia HesseCentro de Neurociencias Cognitivas, Universidad de San Andrés, Victoria, Provincia de Buenos Aires, Argentina.
Enzo TagliazucchiLatin American Brain Health (BrainLat) Institute, Universidad Adolfo Ibáñez, Peñalolén, Región Metropolitana, Chile.
Claudio EstienneInstituto de Ingeniería Biomédica, Universidad de Buenos Aires, Buenos Aires, Argentina.
Cecilia SerranoUnidad de Neurología Cognitiva, Hospital César Milstein, CABA, Argentina.
Andrea SlachevskyNeuropsychology and Clinical Neuroscience Laboratory (LANNEC), Physiopathology Department - ICBM, Neurocience and East Neuroscience Departments, Faculty of Medicine, University of Chile, Providencia, Santiago, Chile.
Diana MatallanaInstituto de Envejecimiento, Department of Psychiatry, School of Medicine, Pontifical Xaverian University, Bogotá, Colombia.
Pablo ReyesCentro de Memoria y Cognición, Intellectus-Hospital Universitario San Ignacio, Bogotá, Colombia.
Agustín IbáñezCentro de Neurociencias Cognitivas, Universidad de San Andrés, Victoria, Provincia de Buenos Aires, Argentina.
Sol FittipaldiCentro de Neurociencias Cognitivas, Universidad de San Andrés, Victoria, Provincia de Buenos Aires, Argentina.
Cecilia Gonzalez CampoCentro de Neurociencias Cognitivas, Universidad de San Andrés, Victoria, Provincia de Buenos Aires, Argentina.
Adolfo M GarcíaCentro de Neurociencias Cognitivas, Universidad de San Andrés, Victoria, Provincia de Buenos Aires, Argentina.

Funding

TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2M
An automated machine learning approach to language changes in Alzheimer’s disease and frontotemporal dementia across Latino and English-speaking populationsR01AG075775 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARIA LUISA GORNO TEMPINI, Adolfo Martin Garcia · 2023 to 2026
$7.2M
US-South American Initiative for Genetic-Neural-Behavioral Interactions in Human Neurodegenerative ResearchR01AG057234 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Claudia Duran-Aniotz, Agustin M. Ibanez · 2019 to 2026
$6.1M
Circadian Disturbance and Dementia in Latin AmericaR01AG083799 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Kun Hu, Agustin M. Ibanez · 2023 to 2026
$3.0M
Alzheimer's Association SG-20-725707NIA NIH HHS P01 AG019724NIA NIH HHS R01 AG057234NIA NIH HHS R01 AG075775
6 · The paper itself

Abstract

introductionVerbal fluency tasks are common in Alzheimer's disease (AD) assessments. Yet, standard valid response counts fail to reveal disease-specific semantic memory patterns. Here, we leveraged automated word-property analysis to capture neurocognitive markers of AD vis-à-vis behavioral variant frontotemporal dementia (bvFTD).

methodsPatients and healthy controls completed two fluency tasks. We counted valid responses and computed each word's frequency, granularity, neighborhood, length, familiarity, and imageability. These features were used for group-level discrimination, patient-level identification, and correlations with executive and neural (magnetic resonanance imaging [MRI], functional MRI [fMRI], electroencephalography [EEG]) patterns.

resultsValid responses revealed deficits in both disorders. Conversely, frequency, granularity, and neighborhood yielded robust group- and subject-level discrimination only in AD, also predicting executive outcomes. Disease-specific cortical thickness patterns were predicted by frequency in both disorders. Default-mode and salience network hypoconnectivity, and EEG beta hypoconnectivity, were predicted by frequency and granularity only in AD. DISCUSSION: Word-property analysis of fluency can boost AD characterization and diagnosis. HIGHLIGHTS: We report novel word-property analyses of verbal fluency in AD and bvFTD. Standard valid response counts captured deficits and brain patterns in both groups. Specific word properties (e.g., frequency, granularity) were altered only in AD. Such properties predicted cognitive and neural (MRI, fMRI, EEG) patterns in AD. Word-property analysis of fluency can boost AD characterization and diagnosis.

Indexed as

Alzheimer DiseaseFrontotemporal DementiaBrainHumansMagnetic Resonance ImagingMemoryMemory DisordersNeuropsychological Testselectroencephalographymachine learningneurodegenerationneuroimagingsemantic memoryword properties

Identifiers

PMID37823470
PMCPMC10916979

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.